XML 41 R22.htm IDEA: XBRL DOCUMENT v3.22.1
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

   For the years ended December 31, 
   2021   2020 
Restricted stock   2,431,515    2,952,499 
Stock options   7,934,851    5,685,539 
Stock purchase warrants   44,700,000    - 
Total   55,066,366    8,638,038 
SCHEDULE OF STOCK BASED COMPENSATION

The following table summarizes stock option-based option compensation for 2021 and 2020, which was allocated as follows:

 

   For the years ended December 31, 
   2021   2020 
Research and development  $1,915,000   $3,126,000 
General and administrative   3,335,000    2,727,000 
Stock option-based compensation expense included in operating expense   5,250,000    5,853,000 
           
Total stock option-based compensation expense   5,250,000    5,853,000 
Tax benefit   -    - 
Stock option-based compensation expense, net of tax  $5,250,000   $5,853,000 
Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
SCHEDULE OF STOCK BASED COMPENSATION

The following table summarizes restricted stock-based compensation for 2021 and 2020, which was allocated as follows:

 

   For the years ended December 31, 
   2021   2020 
Research and development  $1,384,000   $957,000 
General and administrative   2,282,000    1,377,000 
Restricted stock-based compensation expense included in operating expense   3,666,000    2,334,000 
           
Total restricted stock-based compensation expense   3,666,000    2,334,000 
Tax benefit   -    - 
Restricted stock-based compensation expense, net of tax  $3,666,000   $2,334,000